Publications by authors named "Ottavio Di Cillo"
The Covid-19 pandemic affected large part of Italy since February 2020; we, therefore, aimed to assess the impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease (CVD) in Italy. We analyzed data from three telemedicine dispatch centers, one located in Genoa, serving private clients (pharmacies, general practitioners), one in Brescia, serving pharmacies, and one in Bari, serving regional public STEMI network and emergency medical service in Apulia (4 million inhabitants). Demographic data and principal electrocardiogram diagnosis were collected and analyzed.
View Article and Find Full Text PDFArticle Synopsis
- Inflammatory bowel disease (IBD) primarily affects the gastrointestinal wall but can also cause systemic inflammation and various complications outside the intestines due to increased intestinal permeability.
- This systemic inflammation leads to a higher risk of both thrombotic (clots) and bleeding events, particularly during active disease phases, complicating treatment options for affected patients.
- Clinicians face challenges in balancing the risk of bleeding against thrombotic risks while lacking extensive data from large studies, particularly concerning the severe consequences of undertreatment in cases of arterial thromboembolism, such as acute coronary syndromes.
Purpose Of Review: To summarize epidemiology, pathophysiology, prognostic relevance, and treatment options of coronary artery disease (CAD) when coupled with severe aortic stenosis (SAS). In regard to treatment options, we focused on the most recently adopted therapeutic approaches and on the future perspectives in light of the latest percutaneous and surgical technical improvements in the field of both CAD and SAS management.
Recent Findings: Nowadays, SAS is the most common valve disease requiring intervention, either surgical or percutaneous.
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfunction. This condition is the most common cause of death in patients affected by acute myocardial infarction (AMI). Despite early revascularization, prompt optimal medical therapy, and up-to-date mechanical circulatory supports, mortality of patients with CS remains high.
View Article and Find Full Text PDFBackground: Pre-hospital triage with ECG-transmission may reduce time to reperfusion in patients with ST-elevation acute myocardial infarction (STEMI). Less, however, is known on potential benefit of ECG-transmission triage in mountain areas, with complex orography.
Methods: Patients admitted for STEMI and primary coronary angioplasty (pPCI) in a mountain area served by a single cathlab and triaged with ECG-transmission were enrolled in the study and compared with controls: patients' demographics and time to coronary wire were recorded.
Objectives: The aim of this observational study was to determine the benefits of the novel, orally delivered P2Y -inhibitors (Is) in terms of angiographic endpoints and in relation to the time of the loading dose (LD) administration.
Background: The goal of ST-elevation myocardial infarction (STEMI) treatment is timely reperfusion. The P2Y -Is prasugrel and ticagrelor have improved the angiographic outcome of primary percutaneous coronary intervention (pPCI) and patients' prognosis.